Chronic Vaginal Candidiasis

@article{Nwokolo2000ChronicVC,
  title={Chronic Vaginal Candidiasis},
  author={N. Nwokolo and F. Boag},
  journal={Drugs \& Aging},
  year={2000},
  volume={16},
  pages={335-339}
}
Vulvovaginal candidiasis (VVC) is a cause of significant morbidity in many women of a childbearing age worldwide.There is a paucity of literature on the prevalence of this condition in post-menopausal women, although it is believed to be uncommon because of the estrogen dependence of VVC. Postmenopausal women who have underlying risk factors for VVC (e.g. hormone replacement therapy, uncontrolled diabetes mel-litus, immunosuppression caused by medication or disease) may be at risk of chronic or… Expand
Local Treatment of Vulvovaginal Candidosis
TLDR
In summary, azoles and short-term regimens are usually recommended for the local treatment of vulvovaginal candidosis, with nystatin and boric acid considered as second-line alternatives. Expand
Symptomatic vulvovaginal candidiasis and genital colonization by Candida species in Nigeria.
TLDR
The prevalence of vaginal candidiasis among women in Jos was found to be 29.1% and sex education workshops should be conducted for adolescents and young adults in order to educate them on the clinical importance of candidal infections. Expand
Recurrent vulvovaginal candidiasis
TLDR
An approach to a safe and effective assessment of a woman presenting in primary care with symptoms of recurrent vulvovaginal candidiasis (RVVC), which is a common problem in women aged 25-34 years is offered. Expand
Vulvovaginal candidiasis
Vulvovaginal candidiasis is a common condition that will, at some point, affect three-quarters of all women of reproductive age. It is caused by an overgrowth of Candida yeast. There are a number ofExpand
Recurrent fungal vulvovaginitis and its association with vaginal bacterial colonization
TLDR
Evaluating the association between recurrent vulvovaginal fungal infections and bacterial colonization in patients referred to a private specialized center found symptoms most frequently reported were itching, burning, and dyspareunia, while bacterial colonization was diagnosed in 83 patients. Expand
[Frequency of yeasts in vaginal fluid of women with and without clinical suspicion of vulvovaginal candidiasis].
  • J. L. Andrioli, G. S. Oliveira, +4 authors R. Fontana
  • Medicine
  • Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
  • 2009
TLDR
The presence of predisposing factors does not necessarily define vulvovaginal candidiasis and the type of clothing may be one of the reasons for it, according to the patients from the two cities evaluated. Expand
Vaginal thrush: quality of life and treatments.
  • K. Powell
  • Medicine
  • British journal of nursing
  • 2010
TLDR
Vulvovaginal candidiasis, or vaginal thrush, is a common yeast infection experienced by three out of four women at some point in their lives and can lead to depression and sexual problems with partners. Expand
Risk factors of HIV-related oral lesions in adults.
TLDR
Moderate and severe degrees of immunodeficiency and detectable viral loads were risk factors for the onset of oral lesions in HIV-positive adults from Porto Alegre, irrespective of the use of antiretroviral therapy. Expand
New strategies for treatment of Candida vaginal infections.
TLDR
New chemtherapeutic and immunotherapeutic strategies, based on the improved understanding of the immunopathogenesis of this prevalent human infection, will be discussed, including the role of killer antibodies (or their molecular derivatives). Expand
Risk factors of HIV-related oral lesions in adults Fatores de risco de lesões bucais associadas ao HIV em adultos
TLDR
Moderate and severe degrees of immunodefi ciency and detectable viral loads were risk factors for the onset of oral lesions in HIV-positive adults from Porto Alegre, irrespective of the use of antiretroviral therapy. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 20 REFERENCES
Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.
  • J. Sobel
  • Medicine
  • American journal of obstetrics and gynecology
  • 1985
TLDR
Evidence is presented of an increasing incidence of vulvovaginal candidiasis, the cause of which is unclear, but this increase is probably the result of multiple factors including widespread abuse of antibiotics, possibly oral contraceptives, and most important inadequate vaginal therapy. Expand
Recurrent vulvovaginal candidiasis: why does it occur?
TLDR
The current knowledge on vaginal immunological defence mechanisms and the pathogenesis of recurrent VVC is summarized in an attempt to clarify the data and research and aid the clinician’s understanding. Expand
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
  • J. Sobel
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1992
TLDR
Strain typing of sequential clinical isolates by means of molecular techniques indicate a pattern of relapse due to persistent yeast in the vagina rather than frequent vaginal reinfection, and the possibility that an acquired Candida antigen-specific immunological deficiency results in uncontrolled vaginal Candida proliferation and hence repeated clinically evident attacks. Expand
Pathogenesis and Epidemiology of Vulvovaginal Candidiasis
  • J. Sobel
  • Medicine
  • Annals of the New York Academy of Sciences
  • 1988
TLDR
Strain typing of sequential clinical isolates indicates a pattern of vaginal relapse rather than frequent vaginal reinfection, and attempts to reduce attacks by treating sexual partners and suppressing a gastrointestinal tract focus have failed. Expand
Vaginal infections in adult women.
  • J. Sobel
  • Medicine
  • The Medical clinics of North America
  • 1990
Often trivialized by the medical profession, vaginitis in adult women is not only extremely common but is the source of considerable distress and often results in marked suffering. EpidemiologicExpand
Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.
TLDR
It appears that maintenance prophylactic therapy with oral ketoconazole is effective in preventing recurrent episodes of vulvovaginal candidiasis, but that relapse is common after withdrawal of the drug. Expand
Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
  • J. Sobel
  • Medicine
  • Obstetrics and gynecology
  • 1985
TLDR
Prophylactic therapy with oral ketoconazole appears effective in preventing recurrent episodes of vulvovaginal candidiasis and the clinical attack rate of symptomatic episodes was significantly reduced during the one-year observation. Expand
Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.
Although it is the second most common vaginal infection in North America, vulvovaginal candidiasis is a non-notifiable disease and has been excluded from the ranks of sexually transmitted diseases.Expand
RECURRENT VULVOVAGINAL CANDIDIASIS ASSOCIATED WITH LONG‐TERM TAMOXIFEN TREATMENT IN POSTMENOPAUSAL WOMEN
TLDR
Long-term tamoxifen treatment may be complicated by recurrent vulvovaginal candidiasis in postmenopausal women because of the estrogen-dependence of this infection. Expand
Vulvovaginitis in the postmenopausal woman.
TLDR
The differential diagnosis and treatment of sexually transmitted diseases, candidiasis, and vulvar dystrophies are described and various alternatives to estrogen use are included. Expand
...
1
2
...